Carlos Grijalva
Last active: 7/27/2018

  1. Accuracy of pharmacy and coded-diagnosis information in identifying tuberculosis in patients with rheumatoid arthritis. Fiske CT, Griffin MR, Mitchel E, Sterling TR, Grijalva CG (2012) Pharmacoepidemiol Drug Saf 21(6): 666-9
    › Primary publication · 22532509 (PubMed) · PMC3371104 (PubMed Central)
  2. The effect of incident antidiabetic regimens on lipid profiles in veterans with type 2 diabetes: a retrospective cohort. Roumie CL, Huizinga MM, Liu X, Greevy RA, Grijalva CG, Murff HJ, Hung AM, Griffin MR (2011) Pharmacoepidemiol Drug Saf 20(1): 36-44
    › Primary publication · 21182152 (PubMed)
  3. Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems. Herrinton LJ, Curtis JR, Chen L, Liu L, Delzell E, Lewis JD, Solomon DH, Griffin MR, Ouellet-Hellstom R, Beukelman T, Grijalva CG, Haynes K, Kuriya B, Lii J, Mitchel E, Patkar N, Rassen J, Winthrop KL, Nourjah P, Saag KG (2011) Pharmacoepidemiol Drug Saf 20(11): 1199-209
    › Primary publication · 21919113 (PubMed) · PMC3312584 (PubMed Central)
  4. Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. Grijalva CG, Chen L, Delzell E, Baddley JW, Beukelman T, Winthrop KL, Griffin MR, Herrinton LJ, Liu L, Ouellet-Hellstrom R, Patkar NM, Solomon DH, Lewis JD, Xie F, Saag KG, Curtis JR (2011) JAMA 306(21): 2331-9
    › Primary publication · 22056398 (PubMed) · PMC3428224 (PubMed Central)
  5. Healthcare utilization and cost of pneumococcal disease in the United States. Huang SS, Johnson KM, Ray GT, Wroe P, Lieu TA, Moore MR, Zell ER, Linder JA, Grijalva CG, Metlay JP, Finkelstein JA (2011) Vaccine 29(18): 3398-412
    › Primary publication · 21397721 (PubMed)
  6. Emergence of parapneumonic empyema in the USA. Grijalva CG, Zhu Y, Nuorti JP, Griffin MR (2011) Thorax 66(8): 663-8
    › Primary publication · 21617169 (PubMed) · PMC4820002 (PubMed Central)
  7. CRP polymorphisms and chronic kidney disease in the third national health and nutrition examination survey. Hung AM, Ikizler TA, Griffin MR, Glenn K, Greevy RA, Grijalva CG, Siew ED, Crawford DC (2011) BMC Med Genet : 65
    › Primary publication · 21569369 (PubMed) · PMC3119179 (PubMed Central)
  8. Comparisons of persistence and durability among three oral antidiabetic therapies using electronic prescription-fill data: the impact of adherence requirements and stockpiling. Greevy RA, Huizinga MM, Roumie CL, Grijalva CG, Murff H, Liu X, Griffin MR (2011) Clin Pharmacol Ther 90(6): 813-9
    › Primary publication · 22048232 (PubMed)
  9. Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis. Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E, Chen L, Ouellet-Hellstrom R, Herrinton L, Liu L, Mitchel EF, Stein CM, Griffin MR (2011) Arthritis Care Res (Hoboken) 63(10): 1415-24
    › Primary publication · 22121511 (PubMed) · PMC3227007 (PubMed Central)
  10. Assessing the effect of pneumococcal conjugate vaccines: what is the value of routinely collected surveillance data? Grijalva CG, Moore MR, Griffin MR (2011) Lancet Infect Dis 11(10): 724-6
    › Primary publication · 21621465 (PubMed)